return2ozma@lemmy.world to News@lemmy.world · 2 years agoOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comexternal-linkmessage-square100fedilinkarrow-up1497arrow-down111
arrow-up1486arrow-down1external-linkOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comreturn2ozma@lemmy.world to News@lemmy.world · 2 years agomessage-square100fedilink
minus-squareEnderMB@lemmy.worldlinkfedilinkarrow-up6·2 years agoI’m sure there are some costs associated with developing drugs, and I’m sure it’s not cheap. The problem still stands, though, and the solution is capping executive pay in public companies.
I’m sure there are some costs associated with developing drugs, and I’m sure it’s not cheap.
The problem still stands, though, and the solution is capping executive pay in public companies.